372 Neo-adjuvant chemotherapy in locally advanced beast cancer (LABC): FEC (5FU, epirubicin, cyclophosphamide) vs high dose intensity EC + G-CSF (Filgrastim). An EORTC—NCIC—SAKK study. Preliminary results of dose intensity (DI)

✍ Scribed by P. Therasse; C. Tsitsa; T. Sahmoud; E. Tomiak; A. Goldhirsch; M. Piccart

• Book ID: 116167127
• Publisher: Elsevier Science
• Year: 1995
• Tongue: English
• Weight: 154 KB
• Volume: 31
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/0959-8049(95)95625-g